Divided opinion
Amgen v Sanofi: narrowing the scope of protection for antibody inventions?
MAGAZINE EXCLUSIVE
PharmaTimes Magazine Archive
Magazine highlights
View more from the latest edition
Supply chain security
Is blockchain the answer to protecting against counterfeits and medicines shortages?
MAGAZINE EXCLUSIVE
A view from the top
What’s next for account management?
SMART PEOPLE: Jenny Ousbey
OVID Health founder Jenny Ousbey discusses the pandemic, patient advocacy and the Patient Partnership Index
Patient Files: HIV
Samantha Dawson details her experiences living with HIV
HIV: the fight continues
Gilead Sciences’ global patient engagement lead and former HIV nurse specialist Geraldine Reilly explores today’s fight against the virus – as TV series It’s A Sin brings back memories of working on the frontline during the AIDS epidemic of the 1980s and 1990s
Smart People: Dr Nick West
Abbott’s Dr Nick West talks to PharmaTimes about going beyond intervention to improve the care of cardiovascular patients in the UK
The first fallout
Taking a look at the recent dispute between the EU Commission and AstraZeneca over the ins and outs of its contract, Stuart Evans, commercial litigation expert and partner at law firm BLM, examines what this could represent for EU/UK cross-border pharma relations
